Bavachin

Bavachin has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, May 26, 2026: “Bavachin Mitigates Bone Loss via RANKL Inhibition and Runx2 Activation in a Rat Model of Post-menopausal Osteoporosis”.

Intervention

1 paper studies it4 findingsUpdated

PubChem

See all 1 papers on bavachin

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Animals1

What did studies of bavachin find?

4

Studies of bavachin measured 4 outcomes, among them TNFSF11, bone mechanical strength and inflammation.

TNFSF11

downin rats1

1 study
  1. Bavachin decreases TNFSF11 in ovariectomized rats.

    “A decrease in RANKL expression and an upregulation of OPG, Osx, and Runx2 suggest that bavachin effectively modulates bone remodeling pathways and inhibits osteoclast-mediated bone resorption.”

    Animalsin ovariectomized rats

    Bavachin Mitigates Bone Loss via RANKL Inhibition and Runx2 Activation in a Rat Model of Post-menopausal Osteoporosis

    Pharmacognosy Magazine

More on TNFSF11

Bone mechanical strength

upin rats1

1 study
  1. Bavachin improves bone mechanical strength in ovariectomized rats.

    “Bavachin treatment attenuated oxidative stress and inflammation, while improving bone turnover markers and mechanical properties.”

    Animalsin ovariectomized rats

    Bavachin Mitigates Bone Loss via RANKL Inhibition and Runx2 Activation in a Rat Model of Post-menopausal Osteoporosis

    Pharmacognosy Magazine

Inflammation

downin rats1

1 study
  1. Bavachin decreases inflammation in ovariectomized rats.

    “Bavachin treatment attenuated oxidative stress and inflammation, while improving bone turnover markers and mechanical properties.”

    Animalsin ovariectomized rats

    Bavachin Mitigates Bone Loss via RANKL Inhibition and Runx2 Activation in a Rat Model of Post-menopausal Osteoporosis

    Pharmacognosy Magazine

More on Inflammation

Oxidative stress and ROS signaling

downin rats1

1 study
  1. Bavachin decreases oxidative stress and ROS signaling in ovariectomized rats.

    “Bavachin treatment attenuated oxidative stress and inflammation, while improving bone turnover markers and mechanical properties.”

    Animalsin ovariectomized rats

    Bavachin Mitigates Bone Loss via RANKL Inhibition and Runx2 Activation in a Rat Model of Post-menopausal Osteoporosis

    Pharmacognosy Magazine

More on Oxidative stress and ROS signaling

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months